Coronavirus Update: Regeneron Gets Warp Speed Funding, Conflict Slowing Moderna's Progress

Plus: GSK agrees new vaccine collaboration

Operation Warp Speed extends its funding beyond vaccines into antibodies, while insiders say friction between Moderna and US government scientists has caused delays.

Brazil
Brazil's president Jair Bolsonaro, seen here earlier this month in maskless crowds, has tested positive for COVID-19. Brazil has the second-highest number of cases and deaths in the world, after the US.

Regeneron Pharmaceuticals, Inc. has secured $450m from the US government to build out the supply of REGN-COV2, an antibody cocktail in Phase III development for the prevention of COVID-19 infection. The company announced the funding from the Biomedical Advanced Research and Development Authority (BARDA) on 7 July under Operation Warp Speed, a program intended to speed the development of vaccines and treatments to address the health crisis.

The funding will help Regeneron build up the supply of REGN-COV2 before the antibody cocktail has even been shown to...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip